IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas

Author(s):
Cleven, A.H.G.; Suijker, J.; Agrogiannis, G.; Briaire-de Bruijn, I.H.; Frizzell, N.; Hoekstra, A.S.; Wijers-Koster, P.M.; Cleton-Jansen, A.M.; Bovee, J.V.M.G. (0000-0003-1155-0481)
Published
2017
Publication type
Article / Letter to editor
5-Hydroxymethylcytosine5-MethylcytosineHistone methylationChondrosarcomaIsocitrate dehydrogenaseBone tumourEnchondroma
Date issued
2017-05-04
Language
English
Is part of
Clinical Sarcoma Research
hdl
1887/116242
doi
10.1186/s13569-017-0074-6